Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bishop

Showing results (611-620 of 631) with videos related to

Pageof 64
Sort By:
EMBO Reports|June 25, 2024
Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissuesLoïc Rolas, Monja Stein, Anna Barkaway, et al.
Immunity|May 25, 2021
Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damageAnna Barkaway, Loïc Rolas, Régis Joulia, et al.
BMJ Open|March 20, 2024
Talking in primary care (TIP): protocol for a cluster-randomised controlled trial in UK primary care to assess clinical and cost-effectiveness of communication skills e-learning for practitioners on patients' musculoskeletal pain and enablementFelicity L Bishop, Nadia Cross, Rachel Dewar-Haggart, et al.
Health Technology Assessment (Winchester, England)|October 14, 2024
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCTAlexandra Wright-Hughes, Alexander C Ford, Sarah L Alderson, et al.
Cell Metabolism|May 25, 2023
Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunityBenjamin J Jenkins, Julianna Blagih, Fernando M Ponce-Garcia, et al.
Lancet (London, England)|October 20, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C Ford, Alexandra Wright-Hughes, Sarah L Alderson, et al.
Cell Genomics|February 13, 2023
The female protective effect against autism spectrum disorderEmilie M Wigdor, Daniel J Weiner, Jakob Grove, et al.
Developmental Psychology|November 12, 2024
Remote Infant Studies of Early Learning (RISE): Scalable online replications of key findings in infant cognitive developmentElena J Tenenbaum, Caitlin Stone, My H Vu, et al.
The Lancet. Rheumatology|October 24, 2022
Research priorities to reduce the impact of musculoskeletal disorders: a priority setting exercise with the child health and nutrition research initiative methodZoe Paskins, Clare E Farmer, Fay Manning, et al.
Lancet (London, England)|March 9, 2020
Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)David J Beard, Marion K Campbell, Jane M Blazeby, et al.
Pageof 64

Showing results (611-620 of 631) with videos related to

Sort By:
Pageof 64
EMBO Reports|June 25, 2024
Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissuesLoïc Rolas, Monja Stein, Anna Barkaway, et al.
Immunity|May 25, 2021
Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damageAnna Barkaway, Loïc Rolas, Régis Joulia, et al.
BMJ Open|March 20, 2024
Talking in primary care (TIP): protocol for a cluster-randomised controlled trial in UK primary care to assess clinical and cost-effectiveness of communication skills e-learning for practitioners on patients' musculoskeletal pain and enablementFelicity L Bishop, Nadia Cross, Rachel Dewar-Haggart, et al.
Health Technology Assessment (Winchester, England)|October 14, 2024
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCTAlexandra Wright-Hughes, Alexander C Ford, Sarah L Alderson, et al.
Cell Metabolism|May 25, 2023
Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunityBenjamin J Jenkins, Julianna Blagih, Fernando M Ponce-Garcia, et al.
Lancet (London, England)|October 20, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C Ford, Alexandra Wright-Hughes, Sarah L Alderson, et al.
Cell Genomics|February 13, 2023
The female protective effect against autism spectrum disorderEmilie M Wigdor, Daniel J Weiner, Jakob Grove, et al.
Developmental Psychology|November 12, 2024
Remote Infant Studies of Early Learning (RISE): Scalable online replications of key findings in infant cognitive developmentElena J Tenenbaum, Caitlin Stone, My H Vu, et al.
The Lancet. Rheumatology|October 24, 2022
Research priorities to reduce the impact of musculoskeletal disorders: a priority setting exercise with the child health and nutrition research initiative methodZoe Paskins, Clare E Farmer, Fay Manning, et al.
Lancet (London, England)|March 9, 2020
Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)David J Beard, Marion K Campbell, Jane M Blazeby, et al.
Pageof 64